Atox Bio Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.atoxbio.com
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Phase 3
Terminated
- Conditions
- Necrotizing Soft Tissue InfectionPeritonitisAcute Kidney Injury
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- Atox Bio Ltd
- Target Recruit Count
- 58
- Registration Number
- NCT03403751
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸UCSD Medical Center, San Diego, California, United States
🇺🇸University of Missouri, Columbia, Missouri, United States
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Phase 3
Completed
- Conditions
- Fournier's GangreneNecrotizing FasciitisNecrotizing Soft Tissue Infections
- Interventions
- Drug: AB103 0.5 mg/kgOther: NaCl 0.9%
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Atox Bio Ltd
- Target Recruit Count
- 290
- Registration Number
- NCT02469857
- Locations
- 🇺🇸
Maricopa Medical Center, Phoenix, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Cooper University Hospital, Camden, New Jersey, United States
Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients
- First Posted Date
- 2011-08-16
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Atox Bio Ltd
- Target Recruit Count
- 43
- Registration Number
- NCT01417780
- Locations
- 🇺🇸
San Francisco General Hospital, San Francisco, California, United States
🇺🇸University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
AB103 Peptide Antagonist in Healthy Volunteers
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- Atox Bio Ltd
- Target Recruit Count
- 25
- Registration Number
- NCT01166984
- Locations
- 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath